Phase I study of recombinant beta ser 17 interferon in the treatment of cancer. [electronic resource]
Producer: 19870130Description: 1365-72 p. digitalISSN:- 0361-5960
- 2',5'-Oligoadenylate Synthetase -- analysis
- Adult
- Aged
- Antibodies -- analysis
- Chemical and Drug Induced Liver Injury
- Drug Administration Schedule
- Drug Evaluation
- Female
- Hematologic Diseases -- chemically induced
- Humans
- Interferon Type I -- adverse effects
- Interferon beta-1a
- Interferon beta-1b
- Interferon-beta
- Kidney Diseases -- chemically induced
- Kinetics
- Lymphocytes -- enzymology
- Male
- Middle Aged
- Nausea -- chemically induced
- Neoplasms -- blood
- Recombinant Proteins -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.